NRG Therapeutics has dosed the first participants in its Phase I clinical trial of NRG5051, being developed as a ...

Two proteins found on the surface of motor neurons in the brain may be essential in the progression of Parkinson's disease, ...

Parkinson's disease is no longer viewed as a faraway neurological ailment buried in textbooks. More than 10 million people ...

A new UCLA Health study links long-term residential exposure to the pesticide chlorpyrifos with a substantially higher risk of developing Parkinson’s disease. A study led by UCLA Health reports that p ...

Patient-centric trial aiming to evaluate whether bezisterim can help delay disease progression reaches enrollment milestone - ...

It sounds like Lilly did just that. The U.S. pharma announced Wednesday that it was paying $14 per share of Ventyx—more than ...

Explore off times in advanced Parkinson's disease, understand symptoms, communicate with your doctor, and consider treatment strategies and lifestyle adjustments.

Patients wey get movement disorders, including restless legs syndrome (RLS), dey tok say doctors no warn dem about serious ...

Indian American physician to help accelerate commercial readiness for biotechnology firm’s cell therapy for Parkinson’s ...

This perspective argues that Parkinson’s disease may involve functional iron deficiency, where bioavailable iron is limited despite normal or elevated total iron in the brain. The authors propose that ...

In September 2024, NFL legend Brett Favre quietly announced that he was diagnosed with Parkinson’s. It is a progressive ...

NRG Therapeutics Ltd. ('NRG”), a clinical stage neuroscience company targeting a novel mechanism to rectify mitochondrial ...